title: Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-Response.
authors.affiliation: Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: S Michael
authors.initials: SM
authors.lastname: Rothenberg
authors.affiliation: Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Thyroid Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Gilbert H
authors.initials: GH
authors.lastname: Daniels
authors.affiliation: Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. lwirth@partners.org.
authors.forename: Lori J
authors.initials: LJ
authors.lastname: Wirth
mesh_terms: D002277:Carcinoma / Q000235:genetics* / Q000473:pathology*; D002454:Cell Differentiation / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D011836:Radiation Tolerance / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000473:pathology*
chemical_list: D048493:Proto-Oncogene Proteins B-raf